Kelly Shi

Stock Analyst at Jefferies

(3.21)
# 1,048
Out of 5,152 analysts
34
Total ratings
45.45%
Success rate
17.62%
Average return

Stocks Rated by Kelly Shi

ImmunityBio
Dec 12, 2025
Maintains: Buy
Price Target: $8$9
Current: $8.96
Upside: +0.45%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $73$122
Current: $83.52
Upside: +46.07%
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63$77
Current: $63.33
Upside: +21.59%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129$148
Current: $143.57
Upside: +3.09%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23$28
Current: $37.46
Upside: -25.25%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31$44
Current: $14.94
Upside: +194.51%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $6.15
Upside: +143.90%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11$52
Current: $8.53
Upside: +509.61%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18$14
Current: $5.63
Upside: +148.89%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13$19
Current: $26.34
Upside: -27.87%
Maintains: Buy
Price Target: $174$196
Current: $237.35
Upside: -17.42%
Initiates: Buy
Price Target: $21
Current: $5.74
Upside: +265.85%
Initiates: Buy
Price Target: $37
Current: $21.58
Upside: +71.46%
Maintains: Buy
Price Target: $15$6
Current: $2.35
Upside: +155.32%
Initiates: Buy
Price Target: $81
Current: $97.33
Upside: -16.78%
Initiates: Buy
Price Target: $35
Current: $25.25
Upside: +38.61%
Initiates: Buy
Price Target: $36
Current: $3.18
Upside: +1,032.08%
Initiates: Buy
Price Target: $16
Current: $18.02
Upside: -11.21%
Initiates: Buy
Price Target: $20
Current: $17.95
Upside: +11.42%
Initiates: Buy
Price Target: $432
Current: $7.46
Upside: +5,690.88%
Initiates: Buy
Price Target: $52
Current: $13.85
Upside: +275.45%
Initiates: Buy
Price Target: $27
Current: $2.46
Upside: +997.56%
Initiates: Buy
Price Target: $33
Current: $3.02
Upside: +992.72%